Year | Detail |
2000 |
Novo Nordisk splits into three companies namely Novo Nordisk A/S, Novozymes A/S and Novo A/S. |
2001 |
The company acquired Sybron. Won a contract with the U.S. government to develop enzymes for biomass conversion into low-carbon fuel. |
2006 |
The company acquired GroPep and Delta to focus on biopharma business. |
2008 |
The company installed worlds biggest enzyme fermentation facility in China. |
2010 |
The company acquired a Brazilian BioAg company Turfal and launched Cellic product range. |
2014 |
The company launched new product range Medley, with a focus on Americas and Europe. |
2016 |
Separated Biopharma business as a separate company, Albumedix. |
2017 |
The company collaborated with Boeheringer Ingelheim in probiotics and poultry. The company launched products including Spirizyme T Portfolio, Palmora and BioPrep Fusion. |
2020 |
the company acquired PrecisionBiotics and helped in advancing Novozymes human health business futher. |
2021 |
The company acquired Synergia, Microbiome Labs, and the data science platform Biota. They also launched multiple products in the year, namely Formea, Prime, Pristine, and Innova Quantum. |